S&P 500   3,006.14 (-0.02%)
DOW   26,885.48 (+0.22%)
QQQ   192.65 (-0.38%)
AAPL   241.40 (+0.37%)
FB   183.74 (-3.17%)
MSFT   137.25 (-0.85%)
GOOGL   1,243.29 (-0.08%)
AMZN   1,767.53 (-1.02%)
NVDA   197.04 (+0.53%)
GE   8.98 (+2.16%)
AMD   31.73 (-0.94%)
NFLX   268.08 (-3.59%)
BAC   31.24 (+0.68%)
GILD   66.20 (+1.52%)
DIS   132.90 (+2.03%)
S&P 500   3,006.14 (-0.02%)
DOW   26,885.48 (+0.22%)
QQQ   192.65 (-0.38%)
AAPL   241.40 (+0.37%)
FB   183.74 (-3.17%)
MSFT   137.25 (-0.85%)
GOOGL   1,243.29 (-0.08%)
AMZN   1,767.53 (-1.02%)
NVDA   197.04 (+0.53%)
GE   8.98 (+2.16%)
AMD   31.73 (-0.94%)
NFLX   268.08 (-3.59%)
BAC   31.24 (+0.68%)
GILD   66.20 (+1.52%)
DIS   132.90 (+2.03%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 NevroGlaukosICU MedicalNuVasiveTandem Diabetes Care
SymbolNYSE:NVRONYSE:GKOSNASDAQ:ICUINASDAQ:NUVANASDAQ:TNDM
Price Information
Current Price$82.55$62.24$155.13$66.98$62.16
52 Week RangeHoldBuyBuyHoldBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$69.50$74.57$185.00$68.08$75.31
% Upside from Price Target-15.81% downside19.82% upside19.25% upside1.64% upside21.15% upside
Trade Information
Market Cap$2.63 billion$2.36 billion$3.22 billion$3.51 billion$3.73 billion
Beta0.211.690.931.20.19
Average Volume324,612413,900206,332479,3511,265,531
Sales & Book Value
Annual Revenue$387.29 million$181.28 million$1.40 billion$1.10 billion$183.87 million
Price / Sales6.5812.502.293.1619.83
CashflowN/AN/A$11.76 per share$5.22 per shareN/A
Price / CashN/AN/A13.1912.84N/A
Book Value$8.14 per share$4.98 per share$61.67 per share$16.23 per share$2.29 per share
Price / Book10.1412.502.524.1327.14
Profitability
Net Income$-49,210,000.00$-12,950,000.00$28.79 million$12.47 million$-122,610,000.00
EPS($1.64)($0.37)$7.71$2.23($2.55)
Trailing P/E RatioN/AN/A20.1230.04N/A
Forward P/E RatioN/AN/A25.1426.16N/A
P/E GrowthN/AN/AN/A$2.62N/A
Net Margins-24.51%-5.93%3.56%4.65%-19.55%
Return on Equity (ROE)-41.07%-5.77%12.41%15.09%-19.31%
Return on Assets (ROA)-20.43%-4.42%9.99%7.26%-11.55%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.89%0.43%N/A0.79%0.11%
Current Ratio6.05%6.49%3.58%3.60%2.53%
Quick Ratio4.66%6.04%2.31%1.99%2.21%
Ownership Information
Institutional Ownership PercentageN/A96.33%93.62%99.31%79.27%
Insider Ownership Percentage7.60%8.70%11.40%0.97%6.90%
Miscellaneous
Employees8044378,1002,600653
Shares Outstanding30.89 million36.40 million20.67 million52.05 million58.65 million
Next Earnings Date11/6/2019 (Confirmed)11/6/2019 (Estimated)11/14/2019 (Estimated)10/30/2019 (Confirmed)11/4/2019 (Confirmed)
OptionableOptionableOptionableOptionableOptionableOptionable
 NevroGlaukosICU MedicalNuVasiveTandem Diabetes Care

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel